Home
About Us
Core Team
Development History
Corporate Culture
S&T
Research Areas
Technology Platforms
Research and Development
Marketed Products
R&D Products
R&D Pipeline
Academic Progress
Blog
Company News
Media Reports
Join Us
Post-Doctoral Center
Contact Us
Media News
2024-06-13
Biotech Pharma: Pioneers in Sino-BioTech Collaboration
2024-05-27
[Breaking News] ASCO Annual Meeting Announces Study on Nivolumab Plus Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Cancer
[Breaking News] ASCO Annual Meeting Unveils Two Studies on Nivolumab Combined with Immunotherapy for Advanced Esophageal Cancer
2023-10-07
2023 ASTRO | Real-World Study on Nivolumab Combined with Concurrent Chemoradiotherapy for Unresectable Esophageal Cancer
2023 ASTRO | Neoadjuvant Chemoradiotherapy Combined with Nivolumab and Camrelizumab for Potentially Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Prospective, Single-Arm, Phase II Study
2023 ASTRO | Treatment Outcomes of Nivolumab Combined with Radiotherapy in Advanced Nasopharyngeal Cancer Patients Unfit for Concurrent Chemoradiotherapy: A Single-Center Retrospective Study